Avidity Biosciences Ups Public Offering Size
socalTECH
DECEMBER 16, 2022
San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the public of $17.25 per share, and is now expecting to raise $207M for the company. The company said it plans to use the new funding to fund the research and development of its development programs, to continue development work associated with advancing its AOC platform and for working capital and gen
Let's personalize your content